ARDT — Ardent Health Inc.

Summary of Ardent Health's Q1 2026 Earnings Call

1. Key Financial Results and Metrics:

• Revenue: Increased by 7% year-over-year to $1.6 billion.
• Adjusted EBITDA: Grew by 26% to $124 million, with a margin expansion of 110 basis points to 7.7%.
• Adjusted Admissions: Increased by 2%, aligning with the company's guidance range of 1.5% to 2.5%.
• Total Surgeries: Grew by 1.2%, driven primarily by outpatient surgery growth of 1.7%.
• Contract Labor Expenses: Reduced by over 40% to $15 million, improving contract labor as a percentage of salaries, wages, and benefits (SWB) to 2.2%.
• Cash Position: Ended the quarter with $610 million in cash and total debt of $1.1 billion, maintaining a strong balance sheet with total available liquidity of $0.9 billion.

2. Strategic Updates and Business Highlights:

• IMPACT Program: Continued progress with initiatives aimed at optimizing costs and strengthening margins, on track to deliver $55 million in savings for the year.
• Capacity IQ Strategy: Focused on surgeon recruitment and productivity to manage capacity and demand effectively.
• Outpatient Growth: Opened 4 urgent care centers and plans to open additional facilities, including 2 ASCs and 1 freestanding ED.
• AI and Digital Tools: Implemented an AI-assisted virtual care platform across 2,000 patient rooms to enhance patient safety and operational efficiency.

3. Forward Guidance and Outlook:

• The company reaffirmed its full-year financial guidance, maintaining expectations for revenue and adjusted EBITDA growth despite the challenges faced in Q1.
• Anticipated modest EBITDA growth in Q2, with expectations for a stronger second half of the year as operational initiatives take effect.

4. Bad News, Challenges, or Points of Concern:

• Volume Trends: Experienced a 1.1% decrease in total admissions, attributed to severe winter weather and a lighter flu season.
• Payer Mix: Noted a slight decline in core commercial volumes, potentially impacted by macroeconomic conditions.
• Professional Fees: Increased as a percentage of revenue, reflecting ongoing challenges in managing costs associated with professional services.
• Denials and Bad Debt: While denials have stabilized, they remain a concern, with ongoing efforts needed to improve collections and mitigate bad debt.

5. Notable Q&A Insights:

• EBITDA Progression: Management indicated that Q2 and Q3 are expected to be more comparable, with a modest step-up in EBITDA anticipated.
• Payer Mix Trends: The exchange volume saw slight growth, but core commercial volumes were weaker, indicating potential macroeconomic impacts.
• Contract Labor Dynamics: Continued focus on precision staffing and renegotiation of contracts has led to significant improvements in contract labor costs.
• M&A Activity: The company remains open to joint ventures and acquisitions but will proceed cautiously due to macroeconomic uncertainties.
• Medical Malpractice: Noted an increase in premiums, particularly in New Mexico, but legislative changes may provide relief in the future.

Overall, Ardent Health's Q1 2026 results reflect strong operational execution and financial performance despite facing some industry headwinds. The company remains focused on strategic initiatives to enhance margins and manage costs effectively as it navigates a dynamic healthcare environment.